Essays /

Cancer Genetics Inc Cgix Product Essay

Essay preview

Cancer Genetics, Inc. (CGI) is a pharmaceutical company. The company offers DNA-based cancer diagnostics products and services. Its products include DNA-FISH Probes, CGH Microarrays and Next-Generation Sequencing. CGIs oncology tests and laboratory services provide critical genomic information to healthcare professionals, biopharma companies, and cancer centers. The company provides clinical services such as test menu, complete program, expand DX and summation report. It collaborates with Cleveland Clinic, Dana Farber Cancer Institute, Georgia Health Sciences University, Hackensack University Medical Center, Kamineni Hospital, Mayo Clinic, Memorial Sloan-Kettering Cancer Center, and National Cancer Institute. CGI is headquartered in Rutherford, New Jersey, the US.

To Read Complete Report with Toc:

Read more


+1 -1030 -4948 -518 -618 -997 /analysis-details/cancer-genetics-inc-cgix-product-pipeline-analysis-2014-update /analysis/223516 /sample/sample/223516 12207 700 866 90 acquisit action add advantag albani also analysi analyz applic base biopharma brand brows busi buy cancer capabl capit center cgh cgi cgis cgix class cleveland click clinic collabor compani competit competitor complet contact content counter counter-strategi cover creat critic dana data date decis descript design detail develop devic diagnost dna dna-bas dna-fish download drive dx e effect emerg employe end enhanc ensur entri equip estim etc expand expans exploit fact farber fhact figur fish formul free full function gain generat genet genom georgia hackensack head headquart health healthcar help high high-valu hospit identifi in-licens inc includ indic inform institut intellig jersey kamineni ketter key laboratori landscap launch licens like list locat major make market market-entri mayo medic memori menu merger microarray name nation neck new next next-gener ny object offer offic oncolog ongo opportun out-licens overview path pharmaceut phase pipelin plan player portfolio potenti probe product profession profil program promis provid read reason recent regulatori report research return review robust rutherford sale [email protected] scienc scope sequenc servic sloan sloan-kett snapshot sourc specif sponsor stage start state status strategi street strong subsidiari suit summat tabl technic technolog tel territori test toc toll tower trend trial type understand unit univers us valu wherev would